AI SummaryThe corporate metabolic health screening market in India is estimated at ₹2,500–3,500 crore annually by 2027, driven by early-onset hypertension and pre-diabetes in employees aged 20–35—a trend Pazcare's 2026 handbook and Air India's operational alerts confirm. With organized sector employers (airlines, pharma, IT, FMCG) now prioritizing occupational health under the Occupational Safety & Health Code, 2020, and facing productivity losses from undetected metabolic disease, B2B wellness service providers positioned to offer on-site screening + digital follow-up stand to capture 20–30% CAGR. Healthcare entrepreneurs, MBAs in wellness/public health, and paramedical professionals should pursue this opportunity in metros (Delhi, Mumbai, Bangalore, Hyderabad) and Tier 1 pharmaceutical/IT hubs by Q2 2026.
Loading...